The in vivo assay showed that compared with other treatments, PDMP was most effective in inhibiting tumor growth, prolonging survival time, decreasing expression of CD31, CD133, and ALDH1, inducing G1 phase arrest, increasing the apoptosis rate, and in expressing ATM and γ-H2AX. The gene discussed is PECAM1; the disease is neoplasm.